Lord Mandelson, a prominent figure in British politics and former UK Ambassador to the US, extended an invitation to a serving UK Prime Minister for a meeting with Peter Thiel, the co-founder of the highly influential data analytics firm Palantir. This invitation was made during a period when Global Counsel, a lobbying firm co-founded by Lord Mandelson, was actively representing Palantir. The company has since secured substantial contracts with the UK government across critical sectors, including defence and health technology.
The precise timing and details of the meeting between the Prime Minister and Mr. Thiel have not been fully disclosed. However, the connection between Lord Mandelson's role in facilitating such high-level access and Palantir's subsequent success in securing UK government contracts has drawn attention. Palantir, known for its sophisticated data analysis platforms, has been a controversial company due to the nature of its work, often involving sensitive data and intelligence operations.
Global Counsel, established by Lord Mandelson and Benjamin Wegg-Prosser, has been a registered lobbying entity in the UK. The firm's website states that Lord Mandelson does not have a direct lobbying role for any of its clients. However, his prominent position within the firm and his ability to open doors to senior government figures raise questions about the influence exerted by such connections, even if indirect.
The firm is registered with the Office of the Registrar of Consultant Lobbyists (ORCL), the UK's independent statutory body responsible for regulating consultant lobbying. Registration with ORCL requires firms to declare their clients and the government departments they lobby, aiming for transparency in the lobbying process. Despite this, the nature of high-level introductions, particularly those involving former senior government officials, often operates within a less transparent framework.
Palantir's increasing presence in UK public sector projects, particularly within the National Health Service (NHS) and the Ministry of Defence, highlights the significance of these connections. The company's technology is being utilised for various purposes, from managing supply chains and patient data in healthcare to intelligence analysis in defence. The value of these contracts runs into millions of pounds, making the process by which Palantir gains access to decision-makers a matter of public interest.